Booth J R, Munks R, Sokol R J
Trent Regional Blood Transfusion Centre, Sheffield, U.K.
Transfus Med. 1995 Jun;5(2):117-21. doi: 10.1111/j.1365-3148.1995.tb00198.x.
An extract of the albumin gland of Helix pomatia was linked to Sepharose-4B and used to prepare IgA from group O human serum; immunoelectrophoresis showed that the preparation was free of IgG and IgM. From studies with specific IgA subclass antisera and by comparison with the activity of jacalin-produced material the Helix pomatia extract was found to be IgA1 specific. The preparation had red cell anti-A, B specificity and was suitable for standardizing and controlling anti-human IgA reagents. Preparations using six different carbohydrates as eluants inhibited the agglutination reaction between anti-human IgA and IgA-coated red cells to varying degrees. The pattern of reactions suggested that N-acetyl glucosamine was the IgA binding site for Helix pomatia; this differed from its blood group A determinant (N-acetyl galactosamine) which was the same as that for the IgA1 reactive component of jacalin.
将苹果螺白蛋白腺提取物与琼脂糖-4B连接,用于从O型人血清中制备IgA;免疫电泳显示该制剂不含IgG和IgM。通过使用特异性IgA亚类抗血清进行研究,并与jacalin产生的物质的活性进行比较,发现苹果螺提取物对IgA1具有特异性。该制剂具有红细胞抗A、B特异性,适用于标准化和控制抗人IgA试剂。使用六种不同碳水化合物作为洗脱剂的制剂对抗人IgA与IgA包被红细胞之间的凝集反应有不同程度的抑制作用。反应模式表明,N-乙酰葡糖胺是苹果螺的IgA结合位点;这与其血型A决定簇(N-乙酰半乳糖胺)不同,后者与jacalin的IgA1反应成分相同。